Literature DB >> 12485616

CD100/Sema4D, a lymphocyte semaphorin involved in the regulation of humoral and cellular immune responses.

Kazuhiro Suzuki1, Atsushi Kumanogoh, Hitoshi Kikutani.   

Abstract

The semaphorin family consists of soluble and membrane-bound proteins that act as chemorepulsive factors in neuronal development, thereby playing a crucial role in axon guidance. Although they are expressed in a broad range of embryonic and adult tissues, their physiological role outside the nervous system remains to be determined. Recently, emerging evidence has suggested that several semaphorins function as part of the immune system. CD100/Sema4D is the first semaphorin family member for which a critical role in the immune response has been identified. CD100 is involved in several arms of the immune response, including humoral and cell-based immunity. This review will focus on our current understanding of the role of this immunoregulatory semaphorin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12485616     DOI: 10.1016/s1359-6101(02)00073-4

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  8 in total

Review 1.  Semaphorins: a new class of immunoregulatory molecules.

Authors:  Noriko Takegahara; Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

2.  Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury.

Authors:  Li Zhu; Wolfgang Bergmeier; Jie Wu; Hong Jiang; Timothy J Stalker; Marcin Cieslak; Ran Fan; Laurence Boumsell; Atsushi Kumanogoh; Hitoshi Kikutani; Luca Tamagnone; Denisa D Wagner; Marcos E Milla; Lawrence F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-23       Impact factor: 11.205

3.  Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity.

Authors:  Emily M Eriksson; Jeffrey M Milush; Emily L Ho; Mariana D Batista; Sara J Holditch; Chris E Keh; Philip J Norris; Sheila M Keating; Steven G Deeks; Peter W Hunt; Jeffrey N Martin; Michael G Rosenberg; Frederick M Hecht; Douglas F Nixon
Journal:  Blood       Date:  2011-12-01       Impact factor: 22.113

4.  CD100 up-regulation induced by interferon-α on B cells is related to hepatitis C virus infection.

Authors:  Yu He; Yonghong Guo; Yun Zhou; Ying Zhang; Chao Fan; Guangxi Ji; Yu Wang; Zhiyuan Ma; Jianqi Lian; Chunqiu Hao; Zhi Q Yao; Zhansheng Jia
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

Review 5.  Semaphorins and Their Receptors: From Axonal Guidance to Atherosclerosis.

Authors:  Shuhong Hu; Li Zhu
Journal:  Front Physiol       Date:  2018-10-12       Impact factor: 4.566

6.  MiR-125b Suppression Inhibits Apoptosis and Negatively Regulates Sema4D in Avian Leukosis Virus-Transformed Cells.

Authors:  Chaoqi Ren; Ruyu Xie; Yongxiu Yao; Mengmeng Yu; Fangfang Chang; Lixiao Xing; Yao Zhang; Yongzhen Liu; Suyan Wang; Muhammad Farooque; Yongqiang Wang; Xiaole Qi; Changjun Liu; Yanping Zhang; Hongyu Cui; Kai Li; Li Gao; Qing Pan; Venugopal Nair; Xiaomei Wang; Yulong Gao
Journal:  Viruses       Date:  2019-08-07       Impact factor: 5.048

7.  Interferon-α-Enhanced CD100/Plexin-B1/B2 Interactions Promote Natural Killer Cell Functions in Patients with Chronic Hepatitis C Virus Infection.

Authors:  Yu He; Yonghong Guo; Chao Fan; Yingfeng Lei; Yun Zhou; Mingjie Zhang; Chuantao Ye; Guangxi Ji; Li Ma; Jianqi Lian; Jonathan P Moorman; Zhi Q Yao; Jiuping Wang; Chunqiu Hao; Ying Zhang; Zhansheng Jia
Journal:  Front Immunol       Date:  2017-11-03       Impact factor: 7.561

8.  CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion.

Authors:  Rafael Correa-Rocha; Jacobo Lopez-Abente; Carolina Gutierrez; Verónica Astrid Pérez-Fernández; Adrián Prieto-Sánchez; Santiago Moreno-Guillen; María-Ángeles Muñoz-Fernández; Marjorie Pion
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.